Well im certainly no expert but the current GLOBAL market forcast for cell and gene therapy by 2032 is expected to be $44B.......ur talking msb alone to be a $50B company...so unless ur talking the next 10-15 (minimum)? Years then i personally think its unrealistic.....look,like i said iv got alot invested here and have been in and havent sold a share in 4+years and i hope im completely wrong on this but i just cant see $50aud per share at least in the next 10-15 years
Upcoming Newsflow & Re-rate Estimations, page-36
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |